National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3); HR Positive/HER2 Low Breast Cancer | Not yet recruiting | Phase 2 | 2026-01-05 | NCT07317778 | |
| Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Not applicable | 2023-07-18 | NCT05951127 |